Show simple item record

dc.contributor.authorTaylor, Annie
dc.contributor.authorRobinson, W.J.
dc.contributor.authorLauga-Cami, S.
dc.contributor.authorWeaver, G.W.
dc.contributor.authorArroo, R. R. J.
dc.contributor.authorKaiser, M.
dc.contributor.authorGul, S.
dc.contributor.authorKuzikov, M.
dc.contributor.authorEllinger, B.
dc.contributor.authorSingh, K.
dc.contributor.authorSchirmeister, T.
dc.contributor.authorBotana, A.
dc.contributor.authorEurtivong, C.
dc.contributor.authorBhambra, Avninder S.
dc.date.accessioned2020-09-23T14:37:22Z
dc.date.available2020-09-23T14:37:22Z
dc.date.issued2020-09
dc.identifier.citationRobinson, W.J., Taylor, A.E., Lauga-Cami, S., Weaver, G.W., Arroo, R.R.J., Kaiser, M., Gul, S., Kuzikov, M., Singh, K., Schirmeister, T., Botana, A., Eurtivong, C., Bhambra, A.S. (2020) The Discovery of Novel Antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines. European Journal of Medicinal Chemistry,en
dc.identifier.issn0223-5234
dc.identifier.urihttps://dora.dmu.ac.uk/handle/2086/20210
dc.description.abstractHuman African trypanosomiasis, or sleeping sickness, is a neglected tropical disease caused by Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense which seriously affects human health in Africa. Current therapies present limitations in their application, parasite resistance, or require further clinical investigation for wider use. Our work herein describes the design and syntheses of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines, with compound 13, the 4-(2-methoxyphenyl)-6-(pyridine-3-yl)pyrimidin-2-amine demonstrating an IC50 value of 0.38 µM and a promising off-target ADME-Tox profile in vitro. In silico molecular target investigations showed rhodesain to be a putative candidate, supported by STD and WaterLOGSY NMR experiments, however, in vitro evaluation of compound 13 against rhodesain exhibited low experimental inhibition. Therefore, our reported library of drug-like pyrimidines present promising scaffolds for further antikinetoplastid drug development for both phenotypic and target-based drug discovery.en
dc.language.isoenen
dc.publisherElsevieren
dc.subjectantitrypanosomalen
dc.subjectsleeping sicknessen
dc.subjectHuman African Trypanosomiasisen
dc.subjectTrypanosoma brucei rhodesienseen
dc.subjectpyrimidinesen
dc.subjectrhodesainen
dc.subjectdockingen
dc.subjectADME-Toxen
dc.titleThe Discovery of Novel Antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidinesen
dc.typeArticleen
dc.peerreviewedYesen
dc.funderWellcome Trusten
dc.cclicenceCC-BY-NCen
dc.date.acceptance2020-09-09
dc.researchinstituteInstitute for Allied Health Sciences Researchen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record